Jakub Grandos
Jakub Grandos has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Mateusz Polak
Provincial Hospital in Poznan – Greater Poland Specialist Center Poland
6 shared publications - Agnieszka Olejnik
Independent Public Healthcare Institution MSWiA in Lodz, Poland
5 shared publications - Beata Huszcza
Dr. Karol Jonscher Municipal Medical Center in Lodz, Milionowa Street 14, 93-113 Łódź, Poland
5 shared publications - Dominik Gajewski
St. John of God Brothers Hospitaller Hospital in Lodz, Poland
5 shared publications - Jakub Jonakowski
Nikolay Pirogov Specialized District Hospital in Łódź
5 shared publications - Julia Kaczmarek
Independent Public Healthcare Institution MSWiA in Lodz, Poland
5 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 77, 75467
GLP-1-Based Therapies and Relative Energy Deficiency in Sport Among Physically Active Individuals: Plausible Pathways, Evidence Gaps, and Monitoring Considerations
Background. GLP-1 receptor agonists and related incretin-based therapies reduce appetite, energy intake, and body mass. Their growing use and discussion in sport raise concern about possible interactions with low energy availability, although a direct relationship with Relative Energy Deficiency in Sport (REDs) has not been established. Aim. To evaluate how GLP-1-based therapies may intersect with REDs-relevant pathways in physically active individuals while separating established clinical effects, athlete evidence, and untested inference. Materials and Methods. A structured narrative review used three PubMed/MEDLINE search streams addressing GLP-1 therapies and sport, appetite/body composition/exercise pathways, and REDs or low energy availability. Fifty-five full texts were assessed and the evidence was synthesized thematically. Results. Trials conducted mainly in non-athletic populations show reduced hunger, cravings, and laboratory-measured intake; gastrointestinal effects may further limit food tolerance. Weight loss includes variable reductions in lean-mass indices, but these measures do not establish loss of contractile muscle, strength, or performance. Athlete studies separately associate problematic low energy availability with reproductive, bone, endocrine, injury, and selected performance outcomes. No prospective study has tested progression from GLP-1 exposure to problematic low energy availability and REDs in athletes. Conclusions. GLP-1-based therapy should be considered a potential modifying factor within the REDs framework, not a proven cause. Current evidence supports individualized monitoring of treatment indication, weight trajectory, dietary adequacy, gastrointestinal tolerance, training, recovery, body composition, function, reproductive and bone health, and eating behavior. Athlete-specific prospective studies are required.
- 28 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 77, 75467
Open AccessGLP-1-Based Therapies and Relative Energy Deficiency in Sport Among Physically Active Individuals: Plausible Pathways, Evidence Gaps, and Monitoring Considerations
Background. GLP-1 receptor agonists and related incretin-based therapies reduce appetite, energy intake, and body mass. Their growing use and discussion in sport raise concern about possible interactions with low energy availability, although a direct relationship with Relative Energy Deficiency in Sport (REDs) has not been established. Aim. To evaluate how GLP-1-based therapies may intersect with REDs-relevant pathways in physically active individuals while separating established clinical effects, athlete evidence, and untested inference. Materials and Methods. A structured narrative review used three PubMed/MEDLINE search streams addressing GLP-1 therapies and sport, appetite/body composition/exercise pathways, and REDs or low energy availability. Fifty-five full texts were assessed and the evidence was synthesized thematically. Results. Trials conducted mainly in non-athletic populations show reduced hunger, cravings, and laboratory-measured intake; gastrointestinal effects may further limit food tolerance. Weight loss includes variable reductions in lean-mass indices, but these measures do not establish loss of contractile muscle, strength, or performance. Athlete studies separately associate problematic low energy availability with reproductive, bone, endocrine, injury, and selected performance outcomes. No prospective study has tested progression from GLP-1 exposure to problematic low energy availability and REDs in athletes. Conclusions. GLP-1-based therapy should be considered a potential modifying factor within the REDs framework, not a proven cause. Current evidence supports individualized monitoring of treatment indication, weight trajectory, dietary adequacy, gastrointestinal tolerance, training, recovery, body composition, function, reproductive and bone health, and eating behavior. Athlete-specific prospective studies are required.
- Open Access
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75461
Capsaicin-Related Compounds and Exercise Performance in Resistance and High-Intensity Exercise: A Narrative Review
Background. Capsaicin-related compounds, including capsaicin, capsinoids/capsiate, dihydrocapsiate and phenylcapsaicin, are investigated as potential TRPV1-related ergogenic aids, but human exercise evidence remains heterogeneous. Objective. This structured narrative review summarizes human evidence on capsaicin-related compounds in resistance and high-intensity exercise, focusing on performance, rating of perceived exertion (RPE), fatigue, recovery, delayed-onset muscle soreness (DOMS), and selected physiological or neuromuscular outcomes. Methods. A structured PubMed search was supplemented by targeted compound-specific queries. After deduplication and search refinement, 62 unique records were screened by title and Human studies of oral supplementation in resistance, high-intensity, sprint, intermittent, CrossFit-type and recovery-related exercise contexts were prioritized. Findings. Current evidence suggests protocol-specific rather than universal ergogenic effects. Capsaicin showed selected benefits in small male crossover trials involving resistance exercise and high-intensity intermittent exercise, but not in repeated sprinting or continuous high-intensity running. Capsiate and dihydrocapsiate showed mixed findings, with no clear dose-response pattern. Phenylcapsaicin showed preliminary benefits for selected squat, jump, mechanical-performance and soreness-related outcomes, but not consistently for RPE, metabolic markers or whole-session CrossFit Workout-of-the-Day performance. Conclusions. Capsaicin-related compounds may have compound- and protocol-specific ergogenic potential, particularly in selected resistance and intermittent high-intensity settings. However, current evidence is limited by small samples, heterogeneous protocols, inconsistent outcomes and limited independent replication. Larger, well-controlled trials are needed before firm practical recommendations can be made.
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75461
Open AccessCapsaicin-Related Compounds and Exercise Performance in Resistance and High-Intensity Exercise: A Narrative Review
Background. Capsaicin-related compounds, including capsaicin, capsinoids/capsiate, dihydrocapsiate and phenylcapsaicin, are investigated as potential TRPV1-related ergogenic aids, but human exercise evidence remains heterogeneous. Objective. This structured narrative review summarizes human evidence on capsaicin-related compounds in resistance and high-intensity exercise, focusing on performance, rating of perceived exertion (RPE), fatigue, recovery, delayed-onset muscle soreness (DOMS), and selected physiological or neuromuscular outcomes. Methods. A structured PubMed search was supplemented by targeted compound-specific queries. After deduplication and search refinement, 62 unique records were screened by title and Human studies of oral supplementation in resistance, high-intensity, sprint, intermittent, CrossFit-type and recovery-related exercise contexts were prioritized. Findings. Current evidence suggests protocol-specific rather than universal ergogenic effects. Capsaicin showed selected benefits in small male crossover trials involving resistance exercise and high-intensity intermittent exercise, but not in repeated sprinting or continuous high-intensity running. Capsiate and dihydrocapsiate showed mixed findings, with no clear dose-response pattern. Phenylcapsaicin showed preliminary benefits for selected squat, jump, mechanical-performance and soreness-related outcomes, but not consistently for RPE, metabolic markers or whole-session CrossFit Workout-of-the-Day performance. Conclusions. Capsaicin-related compounds may have compound- and protocol-specific ergogenic potential, particularly in selected resistance and intermittent high-intensity settings. However, current evidence is limited by small samples, heterogeneous protocols, inconsistent outcomes and limited independent replication. Larger, well-controlled trials are needed before firm practical recommendations can be made.
- Open Access
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75671
Objective Exercise Outcomes During GLP-1 Based Therapy: Distinguishing Cardiorespiratory Fitness from Walking Capacity. A Narrative Review
Background. Glucagon-like peptide-1 (GLP-1) receptor agonists and related incretin-based therapies can produce substantial weight loss and metabolic benefits. Their effects on objective exercise outcomes are less clear because studies use non-interchangeable endpoints ranging from directly measured oxygen uptake (VO₂) to walking distance. Objective. To summarize objective exercise outcomes during GLP-1-based therapy and separate directly measured cardiorespiratory fitness from changes observed with exercise training and from disease-specific walking capacity. Methods. We searched PubMed and tracked relevant citations up to July 2026. Adult clinical studies reporting at least one objective exercise outcome were grouped by outcome domain. Results. Ten clinical studies were included. In the 193-participant secondary analysis, liraglutide alone did not improve VO₂-derived fitness or physical-performance outcomes. Two smaller trials of exenatide or liraglutide without structured exercise were also neutral. VO₂ improved when structured exercise was included, but comparisons with matched exercise did not establish a clear additive drug effect. Walking outcomes improved most clearly in peripheral artery disease, whereas coronary artery disease and ischemia-focused endpoints were neutral. During substantial weight loss, body-mass-normalized VO₂ may rise partly because body mass in the denominator falls; absolute VO₂, VO₂ normalized to fat-free mass, workload, strength, and body composition therefore require separate interpretation. Conclusions.The meaning of an objective exercise outcome depends on what was measured. Current evidence does not consistently show an independent improvement in directly measured cardiorespiratory fitness with pharmacotherapy alone. Structured exercise remains the best-supported context for improving aerobic fitness. Disease-specific gains in walking capacity should not be interpreted as generalized cardiorespiratory-fitness gains.
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75671
Open AccessObjective Exercise Outcomes During GLP-1 Based Therapy: Distinguishing Cardiorespiratory Fitness from Walking Capacity. A Narrative Review
Background. Glucagon-like peptide-1 (GLP-1) receptor agonists and related incretin-based therapies can produce substantial weight loss and metabolic benefits. Their effects on objective exercise outcomes are less clear because studies use non-interchangeable endpoints ranging from directly measured oxygen uptake (VO₂) to walking distance. Objective. To summarize objective exercise outcomes during GLP-1-based therapy and separate directly measured cardiorespiratory fitness from changes observed with exercise training and from disease-specific walking capacity. Methods. We searched PubMed and tracked relevant citations up to July 2026. Adult clinical studies reporting at least one objective exercise outcome were grouped by outcome domain. Results. Ten clinical studies were included. In the 193-participant secondary analysis, liraglutide alone did not improve VO₂-derived fitness or physical-performance outcomes. Two smaller trials of exenatide or liraglutide without structured exercise were also neutral. VO₂ improved when structured exercise was included, but comparisons with matched exercise did not establish a clear additive drug effect. Walking outcomes improved most clearly in peripheral artery disease, whereas coronary artery disease and ischemia-focused endpoints were neutral. During substantial weight loss, body-mass-normalized VO₂ may rise partly because body mass in the denominator falls; absolute VO₂, VO₂ normalized to fat-free mass, workload, strength, and body composition therefore require separate interpretation. Conclusions.The meaning of an objective exercise outcome depends on what was measured. Current evidence does not consistently show an independent improvement in directly measured cardiorespiratory fitness with pharmacotherapy alone. Structured exercise remains the best-supported context for improving aerobic fitness. Disease-specific gains in walking capacity should not be interpreted as generalized cardiorespiratory-fitness gains.
- Open Access
- 24 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 76123
Swimming-Induced Pulmonary Edema in Open-Water Sports: Implications for Athlete Health and Event Medical Care — A Narrative Review
Background: Swimming-induced pulmonary edema (SIPE) is an uncommon but potentially serious complication of open-water swimming and triathlon. For event medical teams, the challenge extends beyond diagnosis to safe extraction, race-side assessment, respiratory support, and decisions about transfer or discharge.Objective: To review the clinical, physiological, and event-medicine literature on SIPE and develop a practical framework for medical care at mass-participation open-water events.Methods: We searched PubMed/MEDLINE and supplemented the search with Google Scholar, Semantic Scholar, Crossref, publisher websites, and citation tracking. Because the review was intended to inform event medicine, studies conducted in mass-participation settings were given greatest weight, with military, diving, physiological, and other clinical literature used when directly relevant.Results: Direct event evidence is concentrated in a small number of overlapping Vansbro cohorts. In symptomatic swimmers, pulse oximetry and auscultation performed well against LUS-confirmed pulmonary edema; at one low-altitude event, SpO₂ ≤95% or crackles gave 97% sensitivity and 86% specificity. These figures are specific to that setting. Lung ultrasound can add useful information, particularly because edema may be focal or anterior. CPAP and PEP have both been used on site with clinical improvement in observational data, but the available observational data do not establish comparative effectiveness. Crackles and B-lines may persist after symptoms and oxygenation improve. Severe, atypical, or non-resolving presentations require escalation.Conclusions: The literature supports a coherent sequence of event care: preparation, recognition, extraction, assessment, supportive treatment, reassessment, and a decision between escalation and stable disposition, followed by handover and follow-up. The framework proposed here is intended as a practical aid for local adaptation, not as a validated clinical protocol.
- 24 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 76123
Open AccessSwimming-Induced Pulmonary Edema in Open-Water Sports: Implications for Athlete Health and Event Medical Care — A Narrative Review
Background: Swimming-induced pulmonary edema (SIPE) is an uncommon but potentially serious complication of open-water swimming and triathlon. For event medical teams, the challenge extends beyond diagnosis to safe extraction, race-side assessment, respiratory support, and decisions about transfer or discharge.Objective: To review the clinical, physiological, and event-medicine literature on SIPE and develop a practical framework for medical care at mass-participation open-water events.Methods: We searched PubMed/MEDLINE and supplemented the search with Google Scholar, Semantic Scholar, Crossref, publisher websites, and citation tracking. Because the review was intended to inform event medicine, studies conducted in mass-participation settings were given greatest weight, with military, diving, physiological, and other clinical literature used when directly relevant.Results: Direct event evidence is concentrated in a small number of overlapping Vansbro cohorts. In symptomatic swimmers, pulse oximetry and auscultation performed well against LUS-confirmed pulmonary edema; at one low-altitude event, SpO₂ ≤95% or crackles gave 97% sensitivity and 86% specificity. These figures are specific to that setting. Lung ultrasound can add useful information, particularly because edema may be focal or anterior. CPAP and PEP have both been used on site with clinical improvement in observational data, but the available observational data do not establish comparative effectiveness. Crackles and B-lines may persist after symptoms and oxygenation improve. Severe, atypical, or non-resolving presentations require escalation.Conclusions: The literature supports a coherent sequence of event care: preparation, recognition, extraction, assessment, supportive treatment, reassessment, and a decision between escalation and stable disposition, followed by handover and follow-up. The framework proposed here is intended as a practical aid for local adaptation, not as a validated clinical protocol.
- Open Access
- 23 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 70, 74643
Targeted Cervicovestibular Rehabilitation for Persistent Symptoms After Sport-Related Concussion: A Narrative Review
Background: Sport-related concussion (SRC) usually resolves within the expected window, but a subgroup of athletes develops persistent symptoms that delay return-to-play (RTP), possibly reflecting overlapping cervical, vestibular, and vestibulo-ocular contributors rather than one post-concussion syndrome. Aim: To synthesize evidence on cervical, vestibular, and vestibulo-ocular dysfunction after SRC, with emphasis on persistent symptoms, targeted rehabilitation, and RTP. Material and methods: A structured PubMed search identified literature on SRC, persistent symptoms, cervical and vestibulo-ocular dysfunction, and rehabilitation. Full texts were narratively stratified; no pooling or risk-of-bias assessment was performed. Results: Cervical, vestibular, and vestibulo-ocular findings are clinically relevant in athletes with delayed recovery and are associated with persistent symptoms in observational studies. One small randomized trial supports combined cervical-vestibular physiotherapy in youth with persistent dizziness, neck pain, or headache; retrospective data suggest earlier vestibular therapy may shorten recovery, though causality remains unproven. Conclusions: Persistent symptoms after SRC warrant structured reassessment of cervical, vestibular, vestibulo-ocular, balance, and exertional domains. Targeted cervicovestibular rehabilitation appears promising; prospective trials are needed to define referral criteria, timing, sequencing, and RTP criteria.
- 23 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 70, 74643
Open AccessTargeted Cervicovestibular Rehabilitation for Persistent Symptoms After Sport-Related Concussion: A Narrative Review
Background: Sport-related concussion (SRC) usually resolves within the expected window, but a subgroup of athletes develops persistent symptoms that delay return-to-play (RTP), possibly reflecting overlapping cervical, vestibular, and vestibulo-ocular contributors rather than one post-concussion syndrome. Aim: To synthesize evidence on cervical, vestibular, and vestibulo-ocular dysfunction after SRC, with emphasis on persistent symptoms, targeted rehabilitation, and RTP. Material and methods: A structured PubMed search identified literature on SRC, persistent symptoms, cervical and vestibulo-ocular dysfunction, and rehabilitation. Full texts were narratively stratified; no pooling or risk-of-bias assessment was performed. Results: Cervical, vestibular, and vestibulo-ocular findings are clinically relevant in athletes with delayed recovery and are associated with persistent symptoms in observational studies. One small randomized trial supports combined cervical-vestibular physiotherapy in youth with persistent dizziness, neck pain, or headache; retrospective data suggest earlier vestibular therapy may shorten recovery, though causality remains unproven. Conclusions: Persistent symptoms after SRC warrant structured reassessment of cervical, vestibular, vestibulo-ocular, balance, and exertional domains. Targeted cervicovestibular rehabilitation appears promising; prospective trials are needed to define referral criteria, timing, sequencing, and RTP criteria.
- Open Access
- 13 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 57, 72608
Beyond the HPG Axis in Relative Energy Deficiency in Sport: Sleep, Psychological Health, and Neuroendocrine Adaptation in Athletes — A Structured Narrative Review
Background: Relative Energy Deficiency in Sport (REDs) is increasingly viewed as a multisystem condition related to problematic low energy availability (LEA), but evidence beyond reproductive and skeletal outcomes is uneven. Objective: To synthesize evidence on sleep, psychological health and neuroendocrine adaptation in athletes with LEA/REDs, while distinguishing established mechanisms from emerging domains. Methods: A structured narrative review with evidence mapping was conducted in PubMed/MEDLINE; 61 full-text records were assessed and synthesized across predefined domains. Findings: The strongest support concerns endocrine and metabolic adaptation, including thyroid, adipokine, somatotropic and stress-axis pathways, although individual markers remain non-specific. Sleep and psychological outcomes are clinically relevant but rely mainly on heterogeneous, mostly observational evidence. Direct neurocognitive evidence in athletes with well-characterized LEA/REDs remains insufficient. Conclusions: REDs should be considered beyond an HPG-centered framework, but claims regarding sleep, psychological health and neurocognition require caution. Future studies should combine objective LEA characterization, longitudinal designs, endocrine profiling, sleep assessment and direct cognitive testing.
- 13 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 57, 72608
Open AccessBeyond the HPG Axis in Relative Energy Deficiency in Sport: Sleep, Psychological Health, and Neuroendocrine Adaptation in Athletes — A Structured Narrative Review
Background: Relative Energy Deficiency in Sport (REDs) is increasingly viewed as a multisystem condition related to problematic low energy availability (LEA), but evidence beyond reproductive and skeletal outcomes is uneven. Objective: To synthesize evidence on sleep, psychological health and neuroendocrine adaptation in athletes with LEA/REDs, while distinguishing established mechanisms from emerging domains. Methods: A structured narrative review with evidence mapping was conducted in PubMed/MEDLINE; 61 full-text records were assessed and synthesized across predefined domains. Findings: The strongest support concerns endocrine and metabolic adaptation, including thyroid, adipokine, somatotropic and stress-axis pathways, although individual markers remain non-specific. Sleep and psychological outcomes are clinically relevant but rely mainly on heterogeneous, mostly observational evidence. Direct neurocognitive evidence in athletes with well-characterized LEA/REDs remains insufficient. Conclusions: REDs should be considered beyond an HPG-centered framework, but claims regarding sleep, psychological health and neurocognition require caution. Future studies should combine objective LEA characterization, longitudinal designs, endocrine profiling, sleep assessment and direct cognitive testing.
- Open Access
- 16 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
The Role of Physical Activity in Lower Extremity Peripheral Artery Disease.
Peripheral artery disease (PAD) is a common disorder characterised by a reduced blood circulation caused by stenosis or occlusion of peripheral arteries of the limbs, predominantly affecting the lower extremities. This condition is typically related to atherosclerosis, but it might also be caused by vasculitis, fibromuscular dysplasia, or adventitial cystic disease. Although atherosclerotic occlusive disease of the lower extremities has high mortality and morbidity rates, it remains underdiagnosed and undertreated condition. The risk factors of PAD are similar to those for coronary and cerebrovascular disease. The most common symptom of PAD is intermittent claudication, but recent studies show that asymptomatic PAD is several times more common in the population than intermittent claudication. The medical approach to peripheral artery disease is multifaceted and includes smoking cessation, lipid-lowering therapy, antiplatelet therapy, antithrombotic therapy, peripheral vasodilators, blood pressure management, glycemic control and various methods of revascularization. An important, although frequently neglected aspect is an exercise therapy. Walking exercise is first-line therapy for PAD-related walking impairment. Supervised walking exercise and structured home-based walking exercise each not only improve walking ability, but also have other benefits, which we would like to discuss in this review.
- 16 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Open AccessThe Role of Physical Activity in Lower Extremity Peripheral Artery Disease.
Peripheral artery disease (PAD) is a common disorder characterised by a reduced blood circulation caused by stenosis or occlusion of peripheral arteries of the limbs, predominantly affecting the lower extremities. This condition is typically related to atherosclerosis, but it might also be caused by vasculitis, fibromuscular dysplasia, or adventitial cystic disease. Although atherosclerotic occlusive disease of the lower extremities has high mortality and morbidity rates, it remains underdiagnosed and undertreated condition. The risk factors of PAD are similar to those for coronary and cerebrovascular disease. The most common symptom of PAD is intermittent claudication, but recent studies show that asymptomatic PAD is several times more common in the population than intermittent claudication. The medical approach to peripheral artery disease is multifaceted and includes smoking cessation, lipid-lowering therapy, antiplatelet therapy, antithrombotic therapy, peripheral vasodilators, blood pressure management, glycemic control and various methods of revascularization. An important, although frequently neglected aspect is an exercise therapy. Walking exercise is first-line therapy for PAD-related walking impairment. Supervised walking exercise and structured home-based walking exercise each not only improve walking ability, but also have other benefits, which we would like to discuss in this review.
- Open Access
- 19 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 69507
Genetic Determinants of Inter-Individual Variability in Statin Therapy
Statins, or HMG-CoA reductase inhibitors, represent one of the most extensively researched and frequently prescribed pharmacological agents, primarily utilized to reduce cardiovascular risk through the modulation of serum cholesterol levels. Although their efficacy in reducing global mortality and cardiovascular events is well-established, genetic variability persists among different populations which may predispose patients to dose-related adverse effects and reduced efficancy of statin therapy. This heterogeneity has driven a shift in the scientific landscape toward exploring common genetic polymorphisms within the genes encoding genes involved in pharmacodynamic pathways. This review aims to provide a comprehensive analysis of clinically significant polymorphisms within the pharmacodynamic pathways of statins. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria. Conclusions: Despite rapid progress in the field of pharmacogenomics, the role of genetic polymorphisms among genes involved in pharmacodynamic pathways of statin therapy still requires more research in order to establish robust evidence of their role in the overall lipid-lowering efficacy of statins.
- 19 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 69507
Open AccessGenetic Determinants of Inter-Individual Variability in Statin Therapy
Statins, or HMG-CoA reductase inhibitors, represent one of the most extensively researched and frequently prescribed pharmacological agents, primarily utilized to reduce cardiovascular risk through the modulation of serum cholesterol levels. Although their efficacy in reducing global mortality and cardiovascular events is well-established, genetic variability persists among different populations which may predispose patients to dose-related adverse effects and reduced efficancy of statin therapy. This heterogeneity has driven a shift in the scientific landscape toward exploring common genetic polymorphisms within the genes encoding genes involved in pharmacodynamic pathways. This review aims to provide a comprehensive analysis of clinically significant polymorphisms within the pharmacodynamic pathways of statins. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria. Conclusions: Despite rapid progress in the field of pharmacogenomics, the role of genetic polymorphisms among genes involved in pharmacodynamic pathways of statin therapy still requires more research in order to establish robust evidence of their role in the overall lipid-lowering efficacy of statins.
- Open Access
- 15 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
THE EVOLUTION OF AI MEDICAL CONSULTANTS AND THEIR IMPACT ON PATIENT EDUCATION: A LITERATURE REVIEW
Background: The rapid development of Artificial Intelligence (AI) has led to its transition from a theoretical concept in informatics to a functional clinical tool. This study evaluates the impact of AI-based consultants and Large Language Models (LLMs) on patient health literacy and the quality of medical education within the framework of contemporary healthcare standards. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria, 31 key sources were identified and synthesized. Results: LLMs significantly improve the comprehensibility of clinical terminology by adapting medical content to a 9th-11th-grade literacy level. Digital feedback systems, such as the KidneyOnline platform, demonstrate superior efficacy in improving patient adherence compared with standard protocols. However, several critical limitations were identified, including hallucination bias (fabrication of clinical data), a “readability floor” phenomenon associated with up to 83% content reduction, and the risk of professional deskilling among clinicians. Furthermore, wearable devices such as the Apple Watch show high correlation (r=0.92) with medical-grade pulse oximetry, offering new perspectives for real-time health monitoring. Conclusions: AI represents a transformative yet socially consequential innovation in patient education and health literacy. Its responsible implementation requires a strict human-in-the-loop model to ensure clinical safety, ethical accountability, and equitable access. Systematic verification of AI-generated medical information by qualified healthcare professionals remains essential to maintain both high standards of care and public trust in digital health innovations.
- 15 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Open AccessTHE EVOLUTION OF AI MEDICAL CONSULTANTS AND THEIR IMPACT ON PATIENT EDUCATION: A LITERATURE REVIEW
Background: The rapid development of Artificial Intelligence (AI) has led to its transition from a theoretical concept in informatics to a functional clinical tool. This study evaluates the impact of AI-based consultants and Large Language Models (LLMs) on patient health literacy and the quality of medical education within the framework of contemporary healthcare standards. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria, 31 key sources were identified and synthesized. Results: LLMs significantly improve the comprehensibility of clinical terminology by adapting medical content to a 9th-11th-grade literacy level. Digital feedback systems, such as the KidneyOnline platform, demonstrate superior efficacy in improving patient adherence compared with standard protocols. However, several critical limitations were identified, including hallucination bias (fabrication of clinical data), a “readability floor” phenomenon associated with up to 83% content reduction, and the risk of professional deskilling among clinicians. Furthermore, wearable devices such as the Apple Watch show high correlation (r=0.92) with medical-grade pulse oximetry, offering new perspectives for real-time health monitoring. Conclusions: AI represents a transformative yet socially consequential innovation in patient education and health literacy. Its responsible implementation requires a strict human-in-the-loop model to ensure clinical safety, ethical accountability, and equitable access. Systematic verification of AI-generated medical information by qualified healthcare professionals remains essential to maintain both high standards of care and public trust in digital health innovations.
- Open Access
- 7 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 52, 69424
Antidepressant Pharmacotherapy and Structured Physical Activity in Major Depressive Disorder: Implications for Functional Capacity and Cardiometabolic Health
Major depressive disorder (MDD) is a multidimensional condition associated not only with affective symptoms but also with reduced physical activity, impaired functional capacity, and increased cardiometabolic risk. Beyond mood disturbance, depression is frequently accompanied by decreased cardiorespiratory fitness, altered body composition, and autonomic dysregulation. While antidepressant pharmacotherapy remains a cornerstone of treatment, structured physical activity has emerged as a clinically relevant intervention within sports and lifestyle medicine. Evidence from recent meta-analyses and network meta-analyses demonstrates moderate antidepressant effects of aerobic and resistance-based exercise interventions. Comparative analyses suggest similar efficacy of exercise and pharmacotherapy in mild-to-moderate depression, with structured training providing additional benefits for cardiovascular performance, metabolic regulation, and functional recovery. The bidirectional relationship between depression and metabolic syndrome further underscores the importance of addressing systemic risk factors alongside psychiatric symptoms. Antidepressant agents differ in their metabolic, autonomic, and endocrine profiles, with potential implications for weight regulation, insulin sensitivity, and exercise adherence. Overlapping biological mechanisms between pharmacotherapy and physical training include monoaminergic modulation, neuroplasticity enhancement through brain-derived neurotrophic factor pathways, and attenuation of systemic inflammation. However, direct randomized comparisons of combined pharmacotherapy and structured exercise remain limited. An individualized treatment model integrating pharmacological stabilization with progressive physical training may optimize both psychological recovery and longterm physiological resilience in patients with major depressive disorder.
- 7 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 52, 69424
Open AccessAntidepressant Pharmacotherapy and Structured Physical Activity in Major Depressive Disorder: Implications for Functional Capacity and Cardiometabolic Health
Major depressive disorder (MDD) is a multidimensional condition associated not only with affective symptoms but also with reduced physical activity, impaired functional capacity, and increased cardiometabolic risk. Beyond mood disturbance, depression is frequently accompanied by decreased cardiorespiratory fitness, altered body composition, and autonomic dysregulation. While antidepressant pharmacotherapy remains a cornerstone of treatment, structured physical activity has emerged as a clinically relevant intervention within sports and lifestyle medicine. Evidence from recent meta-analyses and network meta-analyses demonstrates moderate antidepressant effects of aerobic and resistance-based exercise interventions. Comparative analyses suggest similar efficacy of exercise and pharmacotherapy in mild-to-moderate depression, with structured training providing additional benefits for cardiovascular performance, metabolic regulation, and functional recovery. The bidirectional relationship between depression and metabolic syndrome further underscores the importance of addressing systemic risk factors alongside psychiatric symptoms. Antidepressant agents differ in their metabolic, autonomic, and endocrine profiles, with potential implications for weight regulation, insulin sensitivity, and exercise adherence. Overlapping biological mechanisms between pharmacotherapy and physical training include monoaminergic modulation, neuroplasticity enhancement through brain-derived neurotrophic factor pathways, and attenuation of systemic inflammation. However, direct randomized comparisons of combined pharmacotherapy and structured exercise remain limited. An individualized treatment model integrating pharmacological stabilization with progressive physical training may optimize both psychological recovery and longterm physiological resilience in patients with major depressive disorder.